{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:53:49Z","timestamp":1791334429085,"version":"4.3.1"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","award":["ANR-24-CE18-2770"],"award-info":[{"award-number":["ANR-24-CE18-2770"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cellimm.2026.105154","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:51:48Z","timestamp":1788533508000},"page":"105154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Is there a role for B cells in Alzheimer's disease?"],"prefix":"10.1016","volume":"428-429","author":[{"given":"Eva-Loren","family":"Charavner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Fillatreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El Behi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2026.105154_bb0005","doi-asserted-by":"crossref","first-page":"1678212","DOI":"10.3389\/fnagi.2025.1678212","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias from 1990 to 2021: findings from the global burden of disease study 2021","volume":"17","author":"Duan","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cellimm.2026.105154_bb0010","doi-asserted-by":"crossref","first-page":"14024","DOI":"10.1038\/s41598-025-97691-z","article-title":"Harmonized prevalence estimates of dementia in Europe vary strongly with childhood education","author":"Borsch-Supan","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2026.105154_bb0015","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.cellimm.2026.105154_bb0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer\u2019s disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cellimm.2026.105154_bb0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.14283\/jpad.2021.23","article-title":"Diagnosis of early Alzheimer\u2019s disease: clinical practice in 2021","author":"Porsteinsson","year":"2021","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.cellimm.2026.105154_bb0035","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(25)01294-2","article-title":"New landscape of the diagnosis of Alzheimer's disease","volume":"406","author":"Frisoni","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.cellimm.2026.105154_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase inhibitors for Alzheimer\u2019s disease","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.cellimm.2026.105154_bb0045","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","author":"Tan","year":"2014","journal-title":"J. Alzheimer's Dis"},{"key":"10.1016\/j.cellimm.2026.105154_bb0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.cellimm.2026.105154_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2026.105154_bb0060","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.cellimm.2026.105154_bb0065","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1042\/BST20221445","article-title":"Gamma-secretase fanning the fire of innate immunity","author":"Liu","year":"2023","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.cellimm.2026.105154_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-022-00588-y","article-title":"TREM2 dependent and independent functions of microglia in Alzheimer\u2019s disease","volume":"17","author":"Hou","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cellimm.2026.105154_bb0075","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1038\/ncomms8333","article-title":"Gamma-secretase directly sheds the survival receptor BCMA from plasma cells","volume":"6","author":"Laurent","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2026.105154_bb0080","article-title":"Morphologic and functional effects of gamma secretase inhibition on splenic marginal zone B cells","volume":"2012","author":"de Vera Mudry","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.cellimm.2026.105154_bb0085","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","author":"Gatz","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.cellimm.2026.105154_bb0090","doi-asserted-by":"crossref","first-page":"200 e213","DOI":"10.1016\/j.neurobiolaging.2016.02.024","article-title":"Assessment of the genetic variance of late-onset Alzheimer\u2019s disease","volume":"41","author":"Ridge","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cellimm.2026.105154_bb0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellimm.2026.105154_bb0100","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1038\/s41380-023-02076-1","article-title":"Step by step: towards a better understanding of the genetic architecture of Alzheimer\u2019s disease","author":"Lambert","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.cellimm.2026.105154_bb0105","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature14252","article-title":"Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease","author":"Gjoneska","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2026.105154_bb0110","first-page":"245","article-title":"Pathways linking Alzheimer's disease risk genes expressed highly in microglia","volume":"8","author":"Hodges","year":"2021","journal-title":"Neuroimmunol. Neuroinflammat."},{"key":"10.1016\/j.cellimm.2026.105154_bb0115","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.cellimm.2026.105154_bb0120","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2026.105154_bb0125","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1002\/j.1460-2075.1996.tb00949.x","article-title":"Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities","volume":"15","author":"McKercher","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.cellimm.2026.105154_bb0130","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1128\/MCB.05817-11","article-title":"SCIMP, a transmembrane adaptor protein involved in major histocompatibility complex class II signaling","author":"Draber","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0135","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk","author":"Jansen","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellimm.2026.105154_bb0140","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellimm.2026.105154_bb0145","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","article-title":"Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer\u2019s disease risk genes","author":"Schwartzentruber","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellimm.2026.105154_bb0150","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1084\/jem.20082100","article-title":"PLC-gamma2 is essential for formation and maintenance of memory B cells","author":"Hikida","year":"2009","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.cellimm.2026.105154_bb0155","doi-asserted-by":"crossref","first-page":"fcaf438","DOI":"10.1093\/braincomms\/fcaf438","article-title":"HLA\u2019s hidden hand in Alzheimer\u2019s disease-five research questions en route to an answer","volume":"7","author":"Capitani","year":"2025","journal-title":"Brain Commun."},{"key":"10.1016\/j.cellimm.2026.105154_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1074-7613(00)80591-9","article-title":"BLNK: a central linker protein in B cell activation","author":"Fu","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2026.105154_bb0165","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2026.105154_bb0170","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer\u2019s disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0175","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2026.105154_bb0180","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2026.105154_bb0185","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","article-title":"The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to Abeta plaques","volume":"27","author":"Sala Frigerio","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellimm.2026.105154_bb0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2023.12.001","article-title":"Tavazoie, an exhausted-like microglial population accumulates in aged and APOE4 genotype Alzheimer\u2019s brains","volume":"57","author":"Millet","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2026.105154_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/science.abo7649","article-title":"Transforming the understanding of brain immunity","volume":"380","author":"Castellani","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2026.105154_bb0200","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","article-title":"Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus","volume":"17","author":"Bettcher","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0205","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nri3857","article-title":"Antibody-independent functions of B cells: a focus on cytokines","author":"Shen","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.954936","article-title":"Role of B cells as antigen presenting cells","volume":"13","author":"Rastogi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0215","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.4049\/jimmunol.177.5.2749","article-title":"B-1 B cell development","author":"Hardy","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0220","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2901","article-title":"The double life of a B-1 cell: self-reactivity selects for protective effector functions","author":"Baumgarth","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0225","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1073\/pnas.0811632106","article-title":"A differentiation pathway for B1 cells in adult bone marrow","author":"Esplin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2026.105154_bb0230","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.autrev.2005.10.007","article-title":"Role of B-1a cells in autoimmunity","author":"Duan","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cellimm.2026.105154_bb0235","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1084\/jem.20062013","article-title":"Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells","author":"Zhang","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2026.105154_bb0240","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1749-6632.1992.tb24615.x","article-title":"IL-10 production by CD5 B cells","volume":"651","author":"O\u2019Garra","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cellimm.2026.105154_bb0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1084\/jem.20101499","article-title":"Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70","author":"Griffin","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2026.105154_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1810144","article-title":"Do human B-1 lymphocytes truly exist?","volume":"17","author":"Martinez-Gutierrez","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fimmu.2011.00063","article-title":"Marginal zone B-cells, a gatekeeper of innate immunity","volume":"2","author":"Zouali","year":"2011","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.coi.2008.03.014","article-title":"Peripheral B cell subsets","author":"Allman","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0265","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.184.6.2271","article-title":"Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice","volume":"184","author":"Wolf","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2026.105154_bb0270","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0275","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2026.105154_bb0280","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1172\/JCI46274","article-title":"Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice","volume":"121","author":"Ding","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2026.105154_bb0285","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2026.105154_bb0290","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.4049\/jimmunol.180.7.4763","article-title":"TLR-activated B cells suppress T cell-mediated autoimmunity","author":"Lampropoulou","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0295","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.4049\/jimmunol.1001307","article-title":"Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis","author":"Matsushita","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0300","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.4049\/jimmunol.1300649","article-title":"Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-gamma+CD4+ T cell numbers during colitis development in mice","volume":"191","author":"Maseda","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0305","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1074-7613(02)00274-1","article-title":"Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation","volume":"16","author":"Mizoguchi","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2026.105154_bb0310","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2026.105154_bb0315","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.0105-2896.2009.00855.x","article-title":"Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of toll-like receptors in immunity","author":"Lampropoulou","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellimm.2026.105154_bb0320","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.4049\/jimmunol.0900270","article-title":"The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals","author":"Yanaba","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0325","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.it.2009.04.005","article-title":"B cells and aging: molecules and mechanisms","author":"Cancro","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12979-020-00210-z","article-title":"Aging induces B cell defects and decreased antibody responses to influenza infection and vaccination","author":"Frasca","year":"2020","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.cellimm.2026.105154_bb0335","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1474-9726.2008.00443.x","article-title":"B-cell diversity decreases in old age and is correlated with poor health status","author":"Gibson","year":"2009","journal-title":"Aging Cell"},{"key":"10.1016\/j.cellimm.2026.105154_bb0340","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1023\/A:1006659401385","article-title":"The effect of age on the B-cell repertoire","volume":"20","author":"Weksler","year":"2000","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0345","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1182\/blood-2011-01-330530","article-title":"A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice","author":"Hao","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2026.105154_bb0350","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2026.105154_bb0355","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood-2011-01-331462","article-title":"Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c(+) B-cell population is important for the development of autoimmunity","author":"Rubtsov","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2026.105154_bb0360","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/s41467-018-03750-7","article-title":"IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(Hi)T-Bet(+) B cells in SLE","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2026.105154_bb0365","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.adf8531","article-title":"The transcription factor ZEB2 drives the formation of age-associated B cells","volume":"383","author":"Dai","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2026.105154_bb0370","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41590-018-0056-8","article-title":"Regulation of age-associated B cells by IRF5 in systemic autoimmunity","author":"Manni","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0375","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41641","article-title":"IFNgamma induces epigenetic programming of human T-Bet(Hi) B cells and promotes TLR7\/8 and IL-21 induced differentiation","volume":"8","author":"Zumaquero","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.cellimm.2026.105154_bb0380","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-immunol-092419-031130","article-title":"Age-associated B cells","volume":"38","author":"Cancro","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0385","doi-asserted-by":"crossref","first-page":"1752452","DOI":"10.3389\/fragi.2026.1752452","article-title":"Age-associated B cells and double-negative B cells: two sides of the same coin? The answer depends on the context","author":"Lamprinou","year":"2026","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cellimm.2026.105154_bb0390","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3233\/JAD-142412","article-title":"Double negative (IgG+IgD-CD27-) B cells are increased in a cohort of moderate-severe Alzheimer\u2019s disease patients and show a pro-inflammatory trafficking receptor phenotype","volume":"44","author":"Bulati","year":"2015","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.cellimm.2026.105154_bb0395","article-title":"Age-associated B cells (ABCs) develop from a CNS-localized progenitor pool into a pro-inflammatory phenotype after stroke","author":"McAtee","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.cellimm.2026.105154_bb0400","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0197-4580(92)90104-6","article-title":"Neuroimmunology of Alzheimer\u2019s disease: a conference report","volume":"13","author":"Dickson","year":"1992","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cellimm.2026.105154_bb0405","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s12264-022-00927-5","article-title":"Focal-type, but not diffuse-type, amyloid Beta plaques are correlated with Alzheimer\u2019s neuropathology, cognitive dysfunction, and neuroinflammation in the human Hippocampus","volume":"38","author":"Liu","year":"2022","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.cellimm.2026.105154_bb0410","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00401-021-02263-w","article-title":"Distinct amyloid-beta and tau-associated microglia profiles in Alzheimer\u2019s disease","volume":"141","author":"Gerrits","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0415","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41593-023-01415-3","article-title":"Infiltrating CD8(+) T cells exacerbate Alzheimer\u2019s disease pathology in a 3D human neuroimmune axis model","volume":"26","author":"Jorfi","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cellimm.2026.105154_bb0420","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/s12276-021-00714-8","article-title":"Single-cell RNA sequencing reveals B cell-related molecular biomarkers for Alzheimer\u2019s disease","volume":"53","author":"Xiong","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.cellimm.2026.105154_bb0425","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.neurobiolaging.2006.05.020","article-title":"Lymphocyte subset patterns and cytokine production in Alzheimer\u2019s disease patients","volume":"28","author":"Speciale","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cellimm.2026.105154_bb0430","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpsychires.2006.01.010","article-title":"Altered lymphocyte distribution in Alzheimer\u2019s disease","volume":"41","author":"Richartz-Salzburger","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.cellimm.2026.105154_bb0435","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0022-510X(92)90284-R","article-title":"The decrease of CD8-positive lymphocytes in Alzheimer\u2019s disease","volume":"107","author":"Pirttila","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cellimm.2026.105154_bb0440","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1182\/blood.V91.1.75","article-title":"Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age","volume":"91","author":"Stephan","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2026.105154_bb0445","doi-asserted-by":"crossref","first-page":"20012","DOI":"10.1073\/pnas.1116110108","article-title":"Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age","volume":"108","author":"Pang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2026.105154_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111391","article-title":"Association of B cell profile and receptor repertoire with the progression of Alzheimer\u2019s disease","volume":"40","author":"Park","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellimm.2026.105154_bb0455","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202217341","article-title":"Functions of double-negative B cells in autoimmune diseases, infections, and cancers","volume":"15","author":"Chung","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cellimm.2026.105154_bb0460","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ni.1716","article-title":"C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE","author":"Reboldi","year":"2009","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.cellimm.2026.105154_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70952","article-title":"A systems immunology analysis of Alzheimer\u2019s disease reveals an age- and environmental exposure-independent disturbance in B cell maturation","volume":"21","author":"Humblet-Baron","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cellimm.2026.105154_bb0470","article-title":"Single-cell RNA sequencing of peripheral blood reveals immune cell signatures in Alzheimer\u2019s disease","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0475","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-150236","article-title":"Increased number of plasma B cells producing autoantibodies against Abeta42 protofibrils in Alzheimer\u2019s disease","volume":"48","author":"Sollvander","year":"2015","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.cellimm.2026.105154_bb0480","first-page":"361","article-title":"Autoantibodies in Alzheimer\u2019s disease: potential biomarkers, pathogenic roles, and therapeutic implications","author":"Wu","year":"2016","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.cellimm.2026.105154_bb0485","doi-asserted-by":"crossref","first-page":"12145","DOI":"10.1073\/pnas.0904866106","article-title":"Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease","volume":"106","author":"Britschgi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2026.105154_bb0490","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ana.21475","article-title":"Autoantibodies against beta-amyloid are common in Alzheimer\u2019s disease and help control plaque burden","volume":"65","author":"Kellner","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0495","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/brain\/awg191","article-title":"Human anti-beta-amyloid antibodies block beta-amyloid fibril formation and prevent beta-amyloid-induced neurotoxicity","volume":"126","author":"Du","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.cellimm.2026.105154_bb0500","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3233\/JAD-180039","article-title":"Lower serum antibodies against tau protein and heavy neurofilament in Alzheimer\u2019s disease","author":"Bartos","year":"2018","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.cellimm.2026.105154_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003488","article-title":"Large-scale seroepidemiology uncovers nephro-urological pathologies in people with tau autoimmunity","volume":"23","author":"Magalhaes","year":"2025","journal-title":"PLoS Biol"},{"key":"10.1016\/j.cellimm.2026.105154_bb0510","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2006.01.072","article-title":"Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer\u2019s disease and healthy subjects","author":"Rosenmann","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cellimm.2026.105154_bb0515","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s12640-020-00161-9","article-title":"Naturally occurring antibodies to tau exists in human blood and are not changed in Alzheimer\u2019s disease","author":"Yu","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.cellimm.2026.105154_bb0520","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/08916934.2015.1008464","article-title":"Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer\u2019s disease","volume":"48","author":"McIntyre","year":"2015","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cellimm.2026.105154_bb0525","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9277","article-title":"Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders","volume":"373","author":"Brioschi","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2026.105154_bb0530","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s41593-018-0213-2","article-title":"Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration","volume":"21","author":"Herisson","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cellimm.2026.105154_bb0535","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbi.2022.11.012","article-title":"B lymphocytes ameliorate Alzheimer\u2019s disease-like neuropathology via interleukin-35","volume":"108","author":"Feng","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cellimm.2026.105154_bb0540","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/s41467-021-22479-4","article-title":"Therapeutic B-cell depletion reverses progression of Alzheimer\u2019s disease","volume":"12","author":"Kim","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2026.105154_bb0545","doi-asserted-by":"crossref","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","article-title":"The adaptive immune system restrains Alzheimer\u2019s disease pathogenesis by modulating microglial function","volume":"113","author":"Marsh","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2026.105154_bb0550","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40478-015-0251-x","article-title":"Reduced beta-amyloid pathology in an APP transgenic mouse model of Alzheimer\u2019s disease lacking functional B and T cells","volume":"3","author":"Spani","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.cellimm.2026.105154_bb0555","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4049\/jimmunol.2000037","article-title":"Depletion of NK cells improves cognitive function in the Alzheimer disease mouse model","author":"Zhang","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2026.105154_bb0560","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/0092-8674(93)90644-6","article-title":"Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting","author":"Gu","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2026.105154_bb0565","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/350423a0","article-title":"A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene","volume":"350","author":"Kitamura","year":"1991","journal-title":"Nature"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492600095X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492600095X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:44:52Z","timestamp":1791333892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000887492600095X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":113,"alternative-id":["S000887492600095X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2026.105154","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there a role for B cells in Alzheimer's disease?","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2026.105154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105154"}}